Characterization of human immunodeficiency virus drug-resistance mutations among individuals with low-level-viremia in low-income and middle-income countries: A meta-analysis

doi:10.5501/wjv.v15.i1.114375

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (15)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-3)

Tables (1-2)

Sum=19

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=14

Mar 25, 2026 (publication date) through Mar 13, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Virol. Mar 25, 2026; 15(1): 114375
Published online Mar 25, 2026. doi: 10.5501/wjv.v15.i1.114375

Open in New Tab Full Size Figure Download Figure

Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-analyses flow diagram of study selection.

Open in New Tab Full Size Figure Download Figure

Figure 2 Sequencing success rate.

Open in New Tab Full Size Figure Download Figure

Figure 3 Pooled prevalence. A: Pooled prevalence of drug resistance mutations (DRM); B: Pooled prevalence of DRM due to nucleoside reverse transcriptase inhibitors; C: Pooled prevalence of DRM due to non-nucleoside reverse transcriptase inhibitors; D: Pooled prevalence of DRM due to protease inhibitor drugs; E: Pooled prevalence of DRM due to integrase strand transfer inhibitor drugs.

Citation: El-Imam IA, Chenya UK, Mbishi JV, Peter TA, Mpimo BK, Ndembi N, Bakari HM, Mbwana MS, Fussi HF, Ally HM, Dababneh SW, Ramadhani HO. Characterization of human immunodeficiency virus drug-resistance mutations among individuals with low-level-viremia in low-income and middle-income countries: A meta-analysis. World J Virol 2026; 15(1): 114375
URL: https://www.wjgnet.com/2220-3249/full/v15/i1/114375.htm
DOI: https://dx.doi.org/10.5501/wjv.v15.i1.114375